Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
CLDN18.2-positive Gastric Adenocarcinoma
×
Gastrointestinal
×
Clear all
Filters
2
NCT01671774
2024-11-14
PILOT
Astellas Pharma Inc
Phase 1
Completed
29 enrolled